About

Mighty Capital is an early-growth Silicon Valley venture capital firm. We look for companies with:
  • a strong leadership team,
  • proven product-market fit, and
  • a clear go-to-market strategy.
We are investors in Digital Ocean, Amplitude and MissionBio. Amplitude calls us the “best value for the dollar invested" and says that our network brought them millions of dollars in revenue. The combination of our diverse partnership expertise and our exclusive access to a global business acceleration platform, Products That Count, helps our portfolio drive sales, hire talent, validate ideas, and exit via corporate M&A. That is why top-tier venture firms like USVP, Mayfield and Aligned Partners invited us to co-invest with them, and why Business Insider says we’ve come up with “a new way of doing venture capital.” If you or someone you know runs a company that meets those criteria, we’d love to hear about it! The best way to get in touch with us is via a mutual connection, most likely a current investor or your law firm. If that’s not an option, then email dealflow@mighty.capital.

Blog


September 4, 2017

A killer pitch deck sounds like a story by design. It is meant to help you step back from the details of your business or new product, to tell a compelling story to an investor. It reads as simple as this: “We are a unique team, excited to solve a big and hard problem. We came up with a sustainably differentiated solution. As a result, we are gaining solid traction, which we monetize fairly. So our financials look extremely promising but to get there, we need a reasonable amount of funding. We have a credible plan to generate significant returns for our investors.”

Read More

February 3, 2017

When a due diligence is appropriate, we ask the entrepreneur to make a data room available to the due diligence team. Through a review of the material in the data room and discussions with the CEO, exec team and references, the due diligence lead is able to cover the key aspects of the due diligence: team, business, financing, and match with Mighty Capital.

Read More

May 14, 2020

In venture capital, the increasing disruption by mega-funds is driving many VCs into the classic innovator’s dilemma: I need to raise bigger funds to survive, but doing so will eventually dilute my returns which will ultimately kill me. The now-classic example is SoftBank who’s founder Masayoshi Son raised $100 billion dollars to invest “unlimited cash” in innovation-crazed companies. Based on my experience navigating three different innovator’s dilemmas, I see two main reasons for this disruptive trend and three ways VC firms might respond. As we’re all navigating towards a new normal, post-COVID-19, these responses will define a new industry direction, and I believe the natural endpoint will be increased fund consolidation activity.

Read More

March 26, 2020

SC Moatti shares some insights and observations on what it takes to be a true value adding member, specifically at an early-stage company. Plus, what’s required during deciding moments, such as fundraising, CEO transition, insolvency, and exits.

Read More

March 5, 2020

Mighty Capital’s Jennifer Vancini sat down recently with Scott Orn, host of the engaging Founders and Friends podcast series, to discuss product-led VC investing. In this series, Scott interviews top VCs, founders and advisors to share their insights on the startup journey. Jennifer describes how Mighty Capital leverages our network of product professionals, through Products That Count and our partners, to evaluate investments and drive value for portfolio companies and investors. She and Scott share laughs and insights as they compare experiences in this dynamic, complicated process.

Read More

February 3, 2020

This article was originally published on Inc Magazine and discusses how as an entrepreneur, your startup needs more than just cash and your investors should help. It features Mighty Capital alongside leading VC firms like Redpoint Ventures and Andreessen Horowitz.

Read More

November 12, 2019

We had a lot of fun at our holiday party and are grateful to the investors, entrepreneurs and friends who were able to join us. This post includes a brief video capturing the vibe of the event.

Read More

August 2, 2019

SC Moatti was honored to recently be interviewed by Innovation Hong Kong. Read about her experience, her thoughts on AI, and a few updates on Mighty Capital and Products That Count.

Read More

July 12, 2019

Deal brings single-cell genomics to China and accelerates Mission Bio’s mission to predict and prevent cancer relapse on a global scale

Read More

June 27, 2019

An effective branding strategy requires seeing your entire constituent universe and transmitting a constant, cohesive and comprehensive values message.

Read More

May 21, 2019

Cancer is smart. Yes, you read that right.

The disease isn’t intelligent in the traditional sense — but cancer cells are adaptable, ‘learning’ from their environment and constantly evolving to improve survival. While targeted therapy can be effective at first, this evolution means that treatment resistance and disease progression remain a challenge.

To effectively combat cancer — to both detect it sooner and develop the most impactful, dynamic therapies — we need to be able to understand it. This means tracking the progression of each and every cancerous cell.

Read More

May 7, 2019

How top marketers are winning against digital-only disruptors by bringing location to the cloud.

Read More

© 2020 Mighty Capital All Rights Reserved